Effect of 12-Week Daily Intake of the High-Lycopene Tomato ( Solanum Lycopersicum ), A Variety Named "PR-7", on Lipid Metabolism: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Tomato ( ) is a rich source of lycopene, a carotenoid that confers various positive biological effects such as improved lipid metabolism. Here, we conducted a randomized, double-blind, placebo-controlled, parallel-group comparative study to investigate the effects of regular and continuous intake of...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients 2019-05, Vol.11 (5), p.1177
Main Authors: Nishimura, Mie, Tominaga, Naoki, Ishikawa-Takano, Yuko, Maeda-Yamamoto, Mari, Nishihira, Jun
Format: Article
Language:English
Subjects:
Adult
Antioxidants
Cardiovascular disease
Carotenoids
Cholesterol
Cholesterol, LDL - blood
Clinical trials
Comparative studies
Cooking
Diet
Disease prevention
Double-Blind Method
Double-blind studies
Evaluation
Feeding Behavior
Female
Food
Humans
Hypercholesterolemia - blood
Hypercholesterolemia - drug therapy
Ingestion
Japan
Laboratory tests
LDL-cholesterol
Lectins
Lipid metabolism
Lipid Metabolism - drug effects
Lipid peroxidation
Lipids
Lipoproteins
Low density lipoprotein
Lycopene
Lycopene - blood
Lycopene - pharmacology
Lycopene - therapeutic use
Lycopersicon esculentum - chemistry
Lycopersicon esculentum - classification
Male
Metabolism
Middle Aged
PR-7
Questionnaires
Randomization
randomized controlled trial
semidried tomato
Species Specificity
Tomatoes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tomato ( ) is a rich source of lycopene, a carotenoid that confers various positive biological effects such as improved lipid metabolism. Here, we conducted a randomized, double-blind, placebo-controlled, parallel-group comparative study to investigate the effects of regular and continuous intake of a new high-lycopene tomato, a variety named PR-7, for 12 weeks, based on 74 healthy Japanese subjects with low-density lipoprotein cholesterol (LDL-C) levels ≥120 to
ISSN:2072-6643
2072-6643
DOI:10.3390/nu11051177